common surface antigens. In many instances this has allowed the assignment of as-yet-unclassified monoclonal antibodies to known CD clusters. More importantly, it has permitted the definition of new surface structures, for which information from any individual laboratory working with one reagent would not have been sufficient to properly characterize a new antigen. In some instances antibodies have been misclassified by submitting laboratories, and the workshop analyses provide a mechanism for correctly identifying the target antigen. This potentially averts many mistakes in research laboratories. It is also of value in clinical therapeutics, since misclassified antibodies have, on a rare occasion, already been in use in clinical protocols. Definition of the CD antigens provides a very helpful framework for further investigation. This is brought about by the direct exchange of information through The Human Leukocyte Differentiation Antigen Workshops.
At the First Workshop, completed in 1982, 137 antibodies were studied and 15 CD clusters designated. At the Fifth Workshop, with participation from more than 500 laboratories, culminating with a meeting in Boston in November 1993, 1,450 antibodies were studied and the list of classified CD antigens was extended to 130.
With the growth of the workshop effort, functional and biochemical studies have become an increasingly important part of the work undertaken, and often provide important clues to the physiologic role of the surface antigens. The use of transfectants and recombinant soluble forms of cell surface molecules has also accelerated the acquisition of new information regarding function and ligands of the various CD antigens. Thus, the Human Leukocyte Differentiation Antigen Workshops have become an important focus for advancing understanding of the structure and function of the CD antigens, as well as classifying them.
What revisions were made to previously established CD clusters? Table 1 indicates revisions to previously established CD clusters (CDI-CD78) made at the Fifth Workshop, and contains information about the function of some of these antigens. When possible, the terminology used has been selected to fit well with other names for known antigens. For example, the selectins have all been clustered within the CD62 grouping as CD62E, L, and P, respectively, designating E-selectin, L-selectin, and P-selectin. Similarly, the expanded CD49 grouping sequentially follows the previously defined VLA and (Y integrin chain designations. One CD antigen, CD67 (not shown in Table l) , has been left as a vacant cluster, since its structure has been found to be most properly grouped in the CD66 cluster. Additional information about these antigens (1) and their cluster revisions (2) has been published. Table 2 lists the new CD antigens clustered at the Fifth Workshop. Many of these are molecules of known functional importance, and many will be of interest to investigators in the rheumatic diseases. When possible, workshop committees attempted to make CD designations easy to remember. For example, ICAM-2 is CD102. Even more helpful, a variety of cytokine receptors for interleukins 1-8 are designated CDw121-CDw128. Known receptors for which antibodies were not available at this workshop, such as the interleukin-3 receptor, earned vacant CD slots for future assignment. Although specific cell lineage panels for many of the new CD antigens are indicated in Table 2 , it is increasingly clear that very few antigens are strictly lineage restricted. A more complete description of the distribution of these various structures is contained in the complete description of the Fifth Workshop proceedings (3). Molecular weights of these structures have been summarized elsewhere (2).
What new CD clusters were established?

What is the future role of the Human Leukocyte Differentiation Antigen Workshops?
The results achieved at the Fifth Workshop and at all previous workshops provide strong momentum for continuation of the workshop effort. The magnitude of the collaborative efforts involved in these workshops provides a model for international scientific cooperation. However, the workshops will have an important role only as long as there are new antigens to be identified, and new structural and functional information to be learned about the CD antigens. That this is the case seems to be beyond question. Even at the Fifth Workshop, several very interesting surface structures were discussed that have been identified so recently that antibodies were not available for exchange at the time of organization of the workshop. Examples of such structures on T lymphocytes include the CD40 ligand and the CTLA4 antigen. New approaches used during the Fifth Workshop are beginning to extend the scope of CD antigens to submembrane and cytoplasmic locations. Endothelial cell and platelet antigens as well as other adhesion ligands are now included within the scope of the workshops, representing an expansion beyond the surface of leukocytes. It seems likely that other nonleukocyte cell types could be added to later workshops.
It can also be expected that information established through workshop framework will be increasingly useful in clinical medicine, both for defining cell markers useful in monitoring diagnoses or stages of disease, and for defining reactivity of antibodies that may be used in clinical therapeutics. It will become increasingly important to develop new models and approaches for understanding the interactions of multiple surface receptors in regulating cell functions in a coordinated manner. The complexity involved is further accentuated by the growing realization that most of the defined surface receptors have multiple ligands, both physiologic and microbial. The tasks for future workshops, therefore, are more complex and difficult than those accomplished to date. Planning for the Sixth Workshop is already well under way, with the workshop conference scheduled for 1996 in Osaka, Japan.
